Circulating and tissue-derived isoforms of bone alkaline phosphatase in Paget's disease of bone

References

• Roodman GD, Windle JJ. Paget disease of bone. J Clin Invest 2005;115:200–8.
   PubMed Web of Science ®Google Scholar
• van Staa TP, Selby PL, Leufkens HGM, Lyles K, Sprafka JM, Cooper C. Incidence and natural history of Paget's disease of bone in England and Wales. J Bone Miner Res 2002;17:465–71.
   PubMed Web of Science ®Google Scholar
• Poór G, Donáth J, Fornet B, Cooper C. Epidemiology of Paget's disease in Europe: the prevalence is decreasing. J Bone Miner Res 2006;21:1545–9.
   PubMed Web of Science ®Google Scholar
• Haddaway MJ, Davie MWJ, McCall IW, Howdle S. Effect of age and gender on the number and distribution of sites in Paget's disease of bone. Br J Radiol 2007;80:532–6.
   PubMed Web of Science ®Google Scholar
• Shankar S, Hosking DJ. Biochemical assessment of Paget's disease of bone. J Bone Miner Res 2006;21(Suppl. 2): P22–P27.
   Google Scholar
• Magnusson P, Löfman O, Larsson L. Determination of alkaline phosphatase isoenzymes in serum by high-performance liquid chromatography with post-column reaction detection. J Chromatogr 1992;576:79–86.
   PubMed Web of Science ®Google Scholar
• Magnusson P, Häger A, Larsson L. Serum osteocalcin and bone and liver alkaline phosphatase isoforms in healthy children and adolescents. Pediatr Res 1995;38:955–61.
   PubMed Web of Science ®Google Scholar
• Magnusson P, Degerblad M, Sääf M, Larsson L, Thorén M. Different responses of bone alkaline phosphatase isoforms during recombinant insulin-like growth factor-I (IGF-I) and during growth hormone therapy in adults with growth hormone deficiency. J Bone Miner Res 1997;12:210–20.
   PubMed Web of Science ®Google Scholar
• Magnusson P, Larsson L, Englund G, Larsson B, Strang P, Selin-Sjögren L. Differences of bone alkaline phosphatase isoforms in metastatic bone disease and discrepant effects of clodronate on different skeletal sites indicated by the location of pain. Clin Chem 1998;44:1621–8.
   PubMed Web of Science ®Google Scholar
• Magnusson P, Sharp CA, Magnusson M, Risteli J, Davie MWJ, Larsson L. Effect of chronic renal failure on bone turnover and bone alkaline phosphatase isoforms. Kidney Int 2001;60:257–65.
   PubMed Web of Science ®Google Scholar
• Millán JL. Mammalian alkaline phosphatase. From biology to applications in medicine and biotechnology. Weinheim, Germany: Wiley-VCH Verlag GmgH & Co. KGaA; 2006.
   Google Scholar
• Halling Linder C, Narisawa S, Millán JL, Magnusson P. Glycosylation differences contribute to distinct catalytic properties among bone alkaline phosphatase isoforms. Bone 2009;45:987–93.
   PubMed Web of Science ®Google Scholar
• Davitz MA, Hereld D, Shak S, Krakow J, Englund PT, Nussenzweig V. A glycan-phosphatidylinositol-specific phospholipase D in human serum. Science 1987;238:81–4.
   PubMed Web of Science ®Google Scholar
• Blom E, Ali MM, Mortensen B, Huseby N-E. Elimination of alkaline phosphatases from circulation by the galactose receptor. Different isoforms are cleared at various rates. Clin Chim Acta 1998;270:125–37.
   PubMed Web of Science ®Google Scholar
• Parfitt AM, Simon LS, Villanueva AR, Krane SM. Procollagen type I carboxy-terminal extension peptide in serum as a marker of collagen biosynthesis in bone. Correlation with Iliac bone formation rates and comparison with total alkaline phosphatase. J Bone Miner Res 1987;2:427–36.
   PubMed Web of Science ®Google Scholar
• Whyte MP. Hypophosphatasia and the role of alkaline phosphatase in skeletal mineralization. Endocr Rev 1994; 15:439–61.
   PubMed Web of Science ®Google Scholar
• Dobnig H, Sipos A, Jiang Y, Fahrleitner-Pammer A, Ste-Marie L-G, Gallagher JC, Pavo I, Wang J, Eriksen EF. Early changes in biochemical markers of bone formation correlate with improvements in bone structure during teriparatide therapy. J Clin Endocrinol Metab 2005;90:3970–7.
   PubMed Web of Science ®Google Scholar
• Magnusson P, Farley JR. Differences in sialic acid residues among bone alkaline phosphatase isoforms: a physical, biochemical, and immunological characterization. Calcif Tissue Int 2002;71:508–18.
   PubMed Web of Science ®Google Scholar
• Magnusson P, Larsson L, Magnusson M, Davie MWJ, Sharp CA. Isoforms of bone alkaline phosphatase: characterization and origin in human trabecular and cortical bone. J Bone Miner Res 1999;14:1926–33.
   PubMed Web of Science ®Google Scholar
• Magnusson P, Sharp CA, Farley JR. Different distributions of human bone alkaline phosphatase isoforms in serum and bone tissue extracts. Clin Chim Acta 2002;325:59–70.
   PubMed Web of Science ®Google Scholar
• Sharp CA, Magnusson P. Isoforms of bone alkaline phosphatase, stem cells, and osteoblast phenotypes. Stem Cells Dev 2008;17:857–8.
   PubMed Web of Science ®Google Scholar
• Sharp CA, Davie MWJ, Worsfold M, Risteli L, Risteli J. Discrepant blood concentrations of type I procollagen propeptides in active Paget disease of bone. Clin Chem 1996; 42:1121–2.
   PubMed Web of Science ®Google Scholar
• Whyte MP. Paget's disease of bone. N Engl J Med 2006; 355:593–600.
   PubMed Web of Science ®Google Scholar
• Marshall MJ, Evans SF, Sharp CA, Powell DE, McCarthy HS, Davie MWJ. Increased circulating Dickkopf-1 in Paget's disease of bone. Clin Biochem 2009;42:965–9.
   PubMed Web of Science ®Google Scholar
• Gomez Jr B, Ardakani S, Ju J, Jenkins D, Cerelli MJ, Daniloff GY, Kung VT. Monoclonal antibody assay for measuring bone-specific alkaline phosphatase activity in serum. Clin Chem 1995;41:1560–6.
   PubMed Web of Science ®Google Scholar
• Broyles DL, Nielsen RG, Bussett EM, Lu WD, Mizrahi IA, Nunnelly PA, Ngo TA, Noell J, Christenson RH, Kress BC. Analytical and clinical performance characteristics of Tandem-MP Ostase, a new immunoassay for serum bone alkaline phosphatase. Clin Chem 1998;44:2139–47.
   PubMed Web of Science ®Google Scholar
• Magnusson P, Årlestig L, Paus E, Di Mauro S, Testa MP, Stigbrand T, Farley JR, Nustad K, Millán JL. Monoclonal antibodies against tissue-nonspecific alkaline phosphatase. Report of the ISOBM TD9 workshop. Tumour Biol 2002; 23:228–48.
   PubMedGoogle Scholar
• Magnusson P, Löfman O, Larsson L. Methodological aspects on separation and reaction conditions of bone and liver alkaline phosphatase isoform analysis by high-performance liquid chromatography. Anal Biochem 1993; 211:156–63.
   PubMed Web of Science ®Google Scholar
• Melkko J, Kauppila S, Niemi S, Risteli L, Haukipuro K, Jukkola A, Risteli J. Immunoassay for intact amino-terminal propeptide of human type I procollagen. Clin Chem 1996; 42:947–54.
   PubMed Web of Science ®Google Scholar
• Brown SJ, Pollintine P, Powell DE, Davie MWJ, Sharp CA. Regional differences in mechanical and material properties of femoral head cancellous bone in health and osteoarthritis. Calcif Tissue Int 2002;71:227–34.
   PubMed Web of Science ®Google Scholar
• Bradford MM. A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding. Anal Biochem 1976;72: 248–54.
   PubMed Web of Science ®Google Scholar
• Panigrahi K, Delmas PD, Singer F, Ryan W, Reiss O, Fisher R, Miller PD, Mizrahi I, Darte C, Kress BC, Christenson RH. Characteristics of a two-site immunoradiometric assay for human skeletal alkaline phosphatase in serum. Clin Chem 1994;40:822–8.
   PubMed Web of Science ®Google Scholar
• Swolin-Eide D, Hansson S, Larsson L, Magnusson P. The novel bone alkaline phosphatase B1x isoform in children with kidney disease. Pediatr Nephrol 2006;21:1723–9.
   PubMed Web of Science ®Google Scholar
• Sharp CA, Linder C, Magnusson P. Analysis of human bone alkaline phosphatase isoforms: comparison of isoelectric focusing and ion-exchange high-performance liquid chromatography. Clin Chim Acta 2007;379:105–12.
   PubMed Web of Science ®Google Scholar
• Naot D, Bava U, Matthews B, Callon KE, Gamble GD, Black M, Song S, Pitto RP, Cundy T, Cornish J, Reid IR. Differential gene expression in cultured osteoblasts and bone marrow stromal cells from patients with Paget's disease of bone. J Bone Miner Res 2007;22:298–309.
   PubMed Web of Science ®Google Scholar
• Eriksen EF, Charles P, Melsen F, Mosekilde L, Risteli L, Risteli J. Serum markers of type I collagen formation and degradation in metabolic bone disease: correlation with bone histomorphometry. J Bone Miner Res 1993;8:127–32.
   PubMed Web of Science ®Google Scholar